SHIVOM Let’s Change The World of Health Around The World With Blockchain-Based Technology

- April 13, 2018

In this post I will discuss a project called Shivom. I think the Shivom project is very promising, because Shivom has a very interesting concept in my opinion, why? Since Shivom is a unique and empowering project, Shivom will allow DNA data donors to collaborate with transformers of revolutionary change in biotechnology, for more details on this project let us consider the following reviews.

Shivom is a unique and empowering project, Shivom will allow DNA data donors to collaborate with revolutionary change transformers in biotechnology, healthcare and government-run research institutions to contribute to an unprecedented era of medical miracle.

In the case of cooperation with the Shivom platform, he will be able to sell his blood information to many interested parties, and there are many of them: pharmaceuticals, research organizations, insurance companies, governments, because by accepting them they can set their immediate goals for this person, analyze and make new vaccines better.

This is a very useful opportunity for the resolution and treatment of many diseases, the production of accurate medicines and the right composition, the planning of sports training and learning how to live better, taking into account my many characteristics to be healthier, energetic and happy.

Shivom is creating a genomics ecosystem on the blockchain. We will offer an open marketplace for healthcare providers to add their apps and services, alongside genomic data analytics and personalized medicine.

Transform genomic data into useable information.
Break down data silos.
Help accelerate clinical trials.
Facilitate drug research and development.
Sponsor sequencing projects to get access to relevant data.

TOKENS

The OmiX Token:

The OmiX token is a key component that enables buying, trading, incentivizing and other services. The token is the fuel of the Shivom ecosystem, as well as part of the governance of the system.

Benefits of OmiX tokens:

Ability to acquire premium services in the Shivom ecosystem
Ability to acquire genome sequencing kits
Ability to sponsor sequencing projects
Ability to acquire access to health/fitness apps from 3rd party providers
Ability to access the genome database
Ability to pay donors for data/participation in research studies
Ability for service providers to use the platform

Shivom will distribute 3 billion OmiX tokens

Token Sale 990M OmiX tokens will be sold during the ICO process.

Community 90M OmiX Tokens will be distributed to the community to grow and nurture the Shivom ecosystem, for bounty programs to leverage network effects, and for community initiatives to reward developers, entrepreneurs, and strategists.

Founders 420M OmiX will be allocated for founders to support the development of the Shivom ecosystem and their continued long-term alignment with the project.

Advisors 300M OmiX will be allocated for early backers and a global network of advisors.

Incentivizing Growth Pool 600M OmiX will be secured in a smart contract, allocated to the database, and introduced into circulation as rewards for data generation.

Company Reserve 600M OmiX will be kept by the Foundation as a reserve fund for future data contribution, running the Foundation and associated non-profit R&D efforts.

The Foundation maintains all authority to utilize a few or the majority of the reserve tokens for future external investors.

TOKEN SALE: USE OF PROCEEDS

The level of funding received dictates the distribution of funds. However, reserve structure allows us to reduce the volatility along the way while achieving long-term objectives.

20% Platform Development Database building, UI, APIs, and metadata curating.

A large part of this budget will be used to make the platform secure and scalable.

From there we will implement new features and create the open marketplace.

11% Operations & Business Development Day-to-day operations, team building (developers, geneticists, marketers and product managers).

Forming the Foundation. 10% Non-Profit R&D Platform Drug discovery platform combining elements of Big Data analytics, artificial intelligence, genomics, proteomics, lipidomics, and metabolomics.

21% Marketing & Forming Partnerships Ongoing community-building events public communications via traditional marketing channels and persona-based approaches.

This also includes educational materials, roadshows, collaboration with other genomics-initiatives, organizing events and conferences, and KOL management.

5% Legal Regulatory compliance for all markets Shivom operates in.

2% Initial PoC First sequencing project in hospitals in rural India.

6% Data Storage Forecasted to sustain the platform during the first few years.

25% Laboratories Setting up a global network of laboratories and counseling services.

Roadmap Shivom